We are live on ! Find out more
CVS icon

CVS Health

1,130 hedge funds and large institutions have $58.3B invested in CVS Health in 2013 Q3 according to their latest regulatory filings, with 86 funds opening new positions, 440 increasing their positions, 470 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 50

2% more funds holding

Funds holding: 1,1071,130 (+23)

2% less capital invested

Capital invested by funds: $59.6B → $58.3B (-$1.33B)

6% less repeat investments, than reductions

Existing positions increased: 440 | Existing positions reduced: 470

1.62% less ownership

Funds ownership: 84.59%82.97% (-1.6%)

18% less call options, than puts

Call options by funds: $227M | Put options by funds: $276M

23% less funds holding in top 10

Funds holding in top 10: 10883 (-25)

Holders
1,130
Holders Change
+23
Holders Change %
+2.08%
% of All Funds
36.63%
Holding in Top 10
83
Holding in Top 10 Change
-25
Holding in Top 10 Change %
-23.15%
% of All Funds
2.69%
New
86
Increased
440
Reduced
470
Closed
50
Calls
$227M
Puts
$276M
Net Calls
-$48.8M
Net Calls Change
-$12.9M
Name Holding Trade Value Shares
Change
Change in
Stake
CCG
1001
Cypress Capital Group
Florida
$255K -$5.96K -100 -2%
T
1002
Thomaspartners
Massachusetts
$253K -$34.6K -580 -11%
BT
1003
Beacon Trust
New Jersey
$253K -$28.7K -481 -10%
HCM
1004
Hodges Capital Management
Texas
$253K -$5.78K -97 -2%
BBA
1005
BLB&B Advisors
Pennsylvania
$253K
FNBSF
1006
First National Bank Sioux Falls
South Dakota
$252K
FWCM
1007
Ferguson Wellman Capital Management
Oregon
$251K -$22.4K -376 -8%
EIM
1008
Emerson Investment Management
Massachusetts
$251K +$263K +4,418 New
Two Sigma Investments
1009
Two Sigma Investments
New York
$251K +$264K +4,433 New
BJL
1010
Brighton Jones LLC
Washington
$250K +$29.9K +501 +13%
BIM
1011
Bridges Investment Management
Nebraska
$249K +$261K +4,385 New
GT
1012
Greenleaf Trust
Michigan
$248K +$28.8K +484 +12%
CIC
1013
Chilton Investment Company
Connecticut
$246K +$259K +4,340 New
AWA
1014
AmeriServ Wealth Advisors
Pennsylvania
$238K
FMWA
1015
Forvis Mazars Wealth Advisors
Missouri
$236K -$5.36K -90 -2%
AA
1016
Apriem Advisors
California
$230K
BP
1017
Ballentine Partners
Massachusetts
$227K +$238K +4,000 New
LD
1018
Lipe & Dalton
New York
$226K -$5.96K -100 -2%
PP
1019
Palladium Partners
Virginia
$225K
ICOA
1020
Investment Centers of America
North Dakota
$224K +$21.9K +367 +11%
FAAM
1021
First Allied Asset Management
California
$223K -$31K -520 -12%
PCM
1022
Prelude Capital Management
New York
$222K -$21.2K -355 -8%
CIP
1023
Convergence Investment Partners
Florida
$221K +$20.5K +344 +10%
HC
1024
Highmount Capital
New York
$220K -$56.6K -950 -20%
DWT
1025
Dorsey & Whitney Trust
South Dakota
$220K +$231K +3,884 New

CVS Hedge Fund Activity: Q3 2013 in Review

1,130 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2013, worth a combined $58.3B — down 2.2% from $59.6B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CVS positions and 50 closed out — a net gain of 36 holders — while 440 added to existing stakes and 470 trimmed.

The largest buyer was abrdn Investment Management, adding an estimated $166M. The largest seller was Fidelity Investments, cutting an estimated $270M.

  • 1,130 institutional investors held CVS Health (CVS) as of Q3 2013, up from 1,107 in Q2 2013.
  • Funds reported $58.3B of CVS Health stock for Q3 2013, down 2.2% quarter-over-quarter.
  • 86 funds opened new CVS Health positions in Q3 2013 and 50 closed out, a net change of +36 holders.
  • The largest CVS Health buyer in Q3 2013 was abrdn Investment Management, an estimated $166M added.
  • The largest CVS Health seller in Q3 2013 was Fidelity Investments, an estimated $270M sold.

Based on aggregated 13F filings for Q3 2013.